Stocks and InvestingStocks and Investing
Wed, June 14, 2023
Tue, June 13, 2023
Mon, June 12, 2023
Fri, June 9, 2023

Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $181 on, Jun 9th, 2023


Published on 2024-10-28 04:17:59 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $181 on, Jun 9th, 2023.

Robert has made no other calls on BNTX in the last 4 months.



There are 9 other peers that have a rating on BNTX. Out of the 9 peers that are also analyzing BNTX, 6 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $120 on, Thursday, May 18th, 2023
  • Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $124 on, Tuesday, May 9th, 2023
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $128 on, Monday, April 10th, 2023
  • Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $153 on, Friday, March 31st, 2023
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $130 on, Tuesday, March 28th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $140 on, Tuesday, March 28th, 2023


These are the ratings of the 3 analyists that currently disagree with Robert


  • Simon Baker of "Redburn Partners" Upgraded from Hold to Strong Buy and Increased Target to $170 on, Wednesday, May 17th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $194 on, Tuesday, March 28th, 2023
  • Bill Selesky of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $203 on, Tuesday, March 28th, 2023